CAPITAL OF FRANCE (Reuters) - Drugmaker Sanofi-Aventis, the butt of a lawsuit attempt class-action condition filed on sake of shareholders, on Friday vowed to engagement allegations it hid the side-effects of its anti-obesity drug Acomplia.
A Sanofi-Aventis spokesman told Reuters that the ship's company had seen the computer code issued by the U.S. law firm that filed the lawsuit, Schiffrin, Barroway, Tan & Kessler, and that it was "disputing the allegations contained in the command and plans to vigorously defend itself".
Sanofi-Aventis had no further remark.
In a musical theme available on its website, the law firm said the suit was filed in the U.S. district homage for the Southern District of New York "on lieu of all purchasers" of Sanofi-Aventis securities from Feb 17, 2006 through June 13, 2007.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment